Takeda in trio of deals

Takeda (Tokyo:4502) announced three deals on Friday covering compounds for cancer, HPV and obesity. Takeda partnered with LG Life Sciences (Seoul, South Korea) to

Read the full 240 word article

How to gain access

Continue reading with a
two-week free trial.